US Stock MarketDetailed Quotes

TERN Terns Pharmaceuticals

Watchlist
  • 6.150
  • -0.090-1.44%
Close Dec 2 16:00 ET
  • 6.189
  • +0.039+0.64%
Post 20:01 ET
522.37MMarket Cap-5211P/E (TTM)

About Terns Pharmaceuticals Company

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-? agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Company Profile

SymbolTERN
Company NameTerns Pharmaceuticals
Listing DateFeb 5, 2021
Issue Price17.00
Founded2017
CEOMs. Amy Burroughs
MarketNASDAQ
Employees66
Fiscal Year Ends12-31
Address1065 East Hillsdale Boulevard,Suite 100
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-525-5535
Websitehttp://www.ternspharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Amy Burroughs
  • Chief Executive Officer and Director
  • --
  • Elona Kogan
  • Chief Legal Officer
  • --
  • Melita Sun Jung
  • Chief Business Officer
  • --
  • Dr. Mark J. Vignola, PhD
  • Principal Accounting Officer, Chief Financial Officer and Treasurer
  • 3.14M
  • Dr. Emil T. Kuriakose, M.D.
  • President and Head, Research and Development
  • --
  • Dr. Erin Quirk, M.D.
  • President and Head of Research and Development
  • 4.67M
  • David Fellows
  • Chairman of the Board
  • 340.15K
  • Heather D. Turner
  • Director
  • --
  • Dr. Radhika Tripuraneni, M.D.,M.P.H.
  • Director
  • 303.06K
  • Dr. Carl L. Gordon, C.F.A.,PhD
  • Independent Director
  • 298.99K
  • Jill M. Quigley, Esq.
  • Independent Director
  • 306.14K
  • Dr. Hongbo Lu, PhD
  • Independent Director
  • 299.99K
  • Jeffrey B. Kindler, Esq.
  • Independent Director
  • 304.99K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data